A First-in-human Phase I Study to Evaluate EMB-15 in Patients With Locally Advanced or Metastatic Solid Tumors.
Clinical trial NCT07607054 · RECRUITING
Trial details
- NCT number
- NCT07607054
- Sponsor
- Shanghai EpimAb Biotherapeutics Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-26
- Primary completion
- 2029-05-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.